We are live on ! Find out more
Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $34.8B
1-Year Est. Return 20.7%
This Fund
S&P 500
This Quarter Est. Return
+5.81%
1 Year Est. Return
+20.7%
3 Year Est. Return
+66.64%
5 Year Est. Return
+79.21%
10 Year Est. Return
+192.59%
AUM
$13B
AUM Growth
+$984M
Cap. Flow
+$180M
Cap. Flow %
1.38%
Top 10 Hldgs %
38.14%
Holding
1,449
New
52
Increased
710
Reduced
341
Closed
132

Top Buys

Rank Stock Value
1
PLD icon
Prologis
PLD
+$287M
2
DLR icon
Digital Realty Trust
DLR
+$150M
3
HR icon
Healthcare Realty
HR
+$110M
4
WELL icon
Welltower
WELL
+$106M
5
O icon
Realty Income
O
+$88.1M

Sector Composition

Rank Sector Weight
1 Real Estate 57.53%
2 Technology 9.67%
3 Healthcare 4.73%
4 Financials 4.38%
5 Consumer Discretionary 3.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LOCL icon
1326
Local Bounti
LOCL
$23.3M
-504
Closed -$19K
LRMR icon
1327
Larimar Therapeutics
LRMR
$398M
-29
Closed
LYFT icon
1328
Lyft
LYFT
$5.87B
-15,691
Closed -$207K
MAXN
1329
DELISTED
Maxeon Solar Technologies
MAXN
-1,988
Closed -$4.72M
NGNE icon
1330
Neurogene
NGNE
$663M
-4
Closed
NIU
1331
Niu Technologies
NIU
$208M
-44,666
Closed -$183K
NRXP icon
1332
NRX Pharmaceuticals
NRXP
$152M
-17
Closed
NXTC icon
1333
NextCure
NXTC
$22.1M
-4
Closed
OLMA icon
1334
Olema Pharmaceuticals
OLMA
$1.01B
-118
Closed
OMER icon
1335
Omeros
OMER
$816M
$0 ﹤0.01%
214
ONDS icon
1336
Ondas Inc
ONDS
$4.48B
-8,988
Closed -$33K
ORIC icon
1337
Oric Pharmaceuticals
ORIC
$1.23B
-135
Closed
OVID icon
1338
Ovid Therapeutics
OVID
$440M
-119
Closed
PASG icon
1339
Passage Bio
PASG
$14.7M
-9
Closed
PBYI icon
1340
Puma Biotechnology
PBYI
$406M
-87
Closed
PRAX icon
1341
Praxis Precision Medicines
PRAX
$8.25B
-9
Closed
PRQR icon
1342
ProQR Therapeutics
PRQR
$248M
-208
Closed
PSNL icon
1343
Personalis
PSNL
$1.27B
-152
Closed
QNCX icon
1344
Quince Therapeutics
QNCX
$18.9M
-1
Closed
RANI icon
1345
Rani Therapeutics
RANI
$92.1M
-58
Closed -$1K
RDHL
1346
Redhill Biopharma
RDHL
$4.44M
0
RIGL icon
1347
Rigel Pharmaceuticals
RIGL
$712M
-37
Closed
RLMD icon
1348
Relmada Therapeutics
RLMD
$549M
-83
Closed -$3K
RLYB icon
1349
Rallybio
RLYB
$85.7M
-12
Closed -$1K
RNAC icon
1350
Cartesian Therapeutics
RNAC
$225M
$0 ﹤0.01%
7

Similar funds

Daiwa Securities Group's Q4 2022 Portfolio in Review

As of Q4 2022, Daiwa Securities Group held 1,449 positions worth $13B, up 8.2% from $12B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Daiwa Securities Group's Q4 2022 filing shows 52 new, 710 increased, 341 reduced and 132 closed positions. Its largest new stake was Atlassian: 9,371 shares worth $1.21M. The largest sale was Duke Realty Corp., an estimated $310M.

By sector, the portfolio is most concentrated in Real Estate at 58% of assets, down from 59% a quarter earlier, followed by Technology and Healthcare.

  • Daiwa Securities Group's largest Q4 2022 buy was Atlassian: 9,371 shares worth $1.21M.
  • Daiwa Securities Group added most to Prologis in Q4 2022, an estimated $287M increase.
  • Daiwa Securities Group's biggest Q4 2022 reduction was Simon Property Group, cutting an estimated $93.4M.
  • Daiwa Securities Group fully exited Duke Realty Corp. in Q4 2022, selling an estimated $310M.
  • Daiwa Securities Group's ten largest holdings make up 38% of its $13B portfolio in Q4 2022.
  • Daiwa Securities Group opened 52 new positions and closed 132 in Q4 2022.
  • Daiwa Securities Group's portfolio value rose 8.2% quarter-over-quarter to $13B.

Based on Daiwa Securities Group's 13F filing for Q4 2022, filed 6 Feb 2023.